GPATFinancial Services · Shell CompaniesGPAT Stock Forecast: GP-Act III Acquisition Corp. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 59 of 100 as at 1 Aug 2026 — in the upper half.
GPAT stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores GP-Act III Acquisition Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (93): The share price has been relatively steady.
Revisions (25): Analysts have, on balance, been cutting their forecasts.
The rank is the raw material. Whether the rules would actually own GP-Act III Acquisition Corp. — and when they’d sell — is the membership.
GPAT stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on GPAT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
GPAT analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
GP-Act III Acquisition Corp. (GPAT) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 35.2×
- Price / sales
- —
- Price / book
- 1.3×
- EV / EBITDA
- −711.8×
Cheaper than 23% of US stocks
Cheaper than 62% of US stocks
Cheaper than 99% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- −25.9%
- Gross margin
- —
- Operating margin
- 0.0%
- Net margin
- 0.0%
Higher than 17% of US stocks
Higher than 35% of US stocks
Higher than 30% of US stocks
- Return on equity
- 4.0%
- Return on assets
- −0.2%
- Dividend yield
- —
Higher than 52% of US stocks
Higher than 43% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
GPAT vs competitors
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| GPATGP-Act III Acquisition Corp. | $392.4M | 59 |
| TACOBerto Acquisition Corp. | $391.3M | 40 |
| BBCQBleichroeder Acquisition Corp. II | $391.0M | 10 |
| ZKPLafayette Digital Acquisition Corp. I | $390.2M | 13 |
| TMSTeamshares, Inc. | $395.9M | 27 |
| RDAGRepublic Digital Acquisition Co. | $388.1M | 41 |
| WENNWen Acquisition Corp. | $387.6M | 35 |
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. GPAT appears on the weeks it earns a place.
Frequently asked questions about GPAT stock
How does Ticker Nerd's model rank GPAT?
As at 1 Aug 2026, GP-Act III Acquisition Corp. ranks 59 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (93 of 100).
What is the GPAT stock forecast for 2030?
No analyst covering GP-Act III Acquisition Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for GPAT are extrapolating price history, which says nothing about the business.
How has GPAT stock performed over the past year?
GP-Act III Acquisition Corp. returned +5.6% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does GP-Act III Acquisition Corp. do?
GP-Act III Acquisition Corp. is a special purpose acquisition company (SPAC) strategically designed to facilitate mergers, capital stock exchanges, asset acquisitions, and other similar business combinations.
About GP-Act III Acquisition Corp.
GP-Act III Acquisition Corp. is a special purpose acquisition company (SPAC) strategically designed to facilitate mergers, capital stock exchanges, asset acquisitions, and other similar business combinations. As a blank check company, GP-Act III operates with no commercial operations and is primarily funded by its initial public offering (IPO). Its primary function is to identify and merge with a promising private company, thereby allowing the private entity access to public markets swiftly and efficiently. GP-Act III focuses on identifying high-potential targets, typically in burgeoning industries, providing these companies with essential capital and a structured path to market presence. SPACs like GP-Act III have become instrumental in the financial markets due to their ability to attract investors looking for opportunities in rising sectors ranging from technology to healthcare. This reflects their significant role in shaping the landscape of public market entry, offering a compelling alternative to traditional IPOs. By bridging the gap between private companies and public markets, GP-Act III Acquisition Corp. plays a vital role in facilitating growth and innovation within the financial ecosystem.
CEO Mr. Antonio Carlos Augusto Ribeiro Bonchristiano · United States · https://www.gp-act3.com